Low-molecular-weight heparins-new frontiers in antithrombotic therapy, San Diego, Calif., December 5, 1997
Author(s)
Bibliographic Information
Low-molecular-weight heparins-new frontiers in antithrombotic therapy, San Diego, Calif., December 5, 1997
（Haemostasis, v. 27 ; Supplement ; 1）
S. Karger, 1997
Available at / 1 libraries
-
No Libraries matched.
- Remove all filters.
Note
Includes bibliographical references and index
Description and Table of Contents
Description
A collection of papers presented at the Super Friday Symposium on Low-Molecular-Weight Heparins. Contributions explore areas such as intrinsic fibrinolytic capacity and systemic inflammation, treatment of thrombotic disorders in cancer patients and low-molecular-weight heparins in angina.
Table of Contents
- Intrinsic fibrinolytic capacity and systemic inflammation - novel risk factors for arterial thrombotic disease, P.M. Ridker
- pathogenesis of thrombosis in coronary artery disease, J.H. Chesebro, et al
- low-molecular-weight heparins and unstable angina - current perspectives, A.G.G. Turpie
- markers of hypercoagulability in cancer patients, P.M. Mannucci
- prevention of venous thromboembolism in cancer using low-molecular-weight heparins, A.K. Kakkar and R.C.N. Williamson
- treatment of thrombotic disorders in cancer patients, M. Levine
- summary of symposium, V.V. Kakkar.
by "Nielsen BookData"